Emerging Agents in the Pipeline for Merkel Cell Carcinoma
3 Visningar
• 07/17/23
0
0
Bädda in
administrator
Prenumeranter
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna